Seurat Therapeutics

Home
About
Pipeline
News & Publication
- In the News
- Publications

Improving Health Through Targeting Nuclear Receptors

ABOUT SEURAT THERAPEUTICS

Seurat Therapeutics is a privately held biopharmaceutical company headquartered in Chicago, Illinois. The company’s mission is to transform neurological research breakthroughs into novel medications to treat debilitating nervous system disorders; such as migraine headaches, fibromyalgia, other chronic pain syndromes, and epileptic seizure disorders.

The Art of Pain Relief

Did you know… many art historians believe George-Pierre Seurat’s unique pointillistic painting style was inspired by the famous artist’s own migraines, specifically, migraines with aura? This is why when migraine patients see visual distortions like scintillating aura, neurologists sometimes refer to them as experiencing the “Seurat effect”.